190 related articles for article (PubMed ID: 8296645)
1. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titers in patients with Wegener's granulomatosis.
Kerr GS; Fleisher TA; Hallahan CW; Leavitt RY; Fauci AS; Hoffman GS
Adv Exp Med Biol; 1993; 336():411-4. PubMed ID: 8296645
[TBL] [Abstract][Full Text] [Related]
2. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis.
Kerr GS; Fleisher TA; Hallahan CW; Leavitt RY; Fauci AS; Hoffman GS
Arthritis Rheum; 1993 Mar; 36(3):365-71. PubMed ID: 8452581
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener's granulomatosis.
Soukiasian SH; Foster CS; Niles JL; Raizman MB
Ophthalmology; 1992 Jan; 99(1):125-32. PubMed ID: 1741124
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis.
Rao JK; Allen NB; Feussner JR; Weinberger M
Lancet; 1995 Oct; 346(8980):926-31. PubMed ID: 7564726
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis and other diseases: clinical issues.
Galperin C; Hoffman GS
Cleve Clin J Med; 1994; 61(6):416-27. PubMed ID: 7828332
[TBL] [Abstract][Full Text] [Related]
6. Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis.
Kyndt X; Reumaux D; Bridoux F; Tribout B; Bataille P; Hachulla E; Hatron PY; Duthilleul P; Vanhille P
Am J Med; 1999 May; 106(5):527-33. PubMed ID: 10335724
[TBL] [Abstract][Full Text] [Related]
7. The hearing loss in Wegener's granulomatosis: relationship between hearing loss and serum ANCA.
Okamura H; Ohtani I; Anzai T
Auris Nasus Larynx; 1992; 19(1):1-6. PubMed ID: 1514941
[TBL] [Abstract][Full Text] [Related]
8. The nosology of Wegener's granulomatosis utilizing the elk format augmented by c-ANCA.
DeRemee RA
Adv Exp Med Biol; 1993; 336():209-15. PubMed ID: 8296609
[No Abstract] [Full Text] [Related]
9. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.
van de Wiel BA; Dolman KM; van der Meer-Gerritsen CH; Hack CE; von dem Borne AE; Goldschmeding R
Clin Exp Immunol; 1992 Dec; 90(3):409-14. PubMed ID: 1458677
[TBL] [Abstract][Full Text] [Related]
10. Negative ANCA in Wegener's granulomatosis.
Carrie S; Hughes KB; Watson MG
J Laryngol Otol; 1994 May; 108(5):420-2. PubMed ID: 8035124
[TBL] [Abstract][Full Text] [Related]
11. Severe CNS manifestations as the clinical hallmark in generalized Wegener's granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literature.
Reinhold-Keller E; de Groot K; Holl-Ulrich K; Arlt AC; Heller M; Feller AC; Gross WL
Clin Exp Rheumatol; 2001; 19(5):541-9. PubMed ID: 11579713
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders.
Kallenberg CG; Mulder AH; Tervaert JW
Am J Med; 1992 Dec; 93(6):675-82. PubMed ID: 1466365
[TBL] [Abstract][Full Text] [Related]
13. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA.
Mulder AH; Stegeman CA; Kallenberg CG
Clin Exp Immunol; 1995 Aug; 101(2):227-32. PubMed ID: 7648707
[TBL] [Abstract][Full Text] [Related]
14. Little evidence for anti-endothelial-cell antibodies in microscopic polyarteritis and Wegener's granulomatosis.
Varagunam M; Nwosu AC; Adu D; Garner C; Taylor CM; Michael J; Thompson RA
Adv Exp Med Biol; 1993; 336():419-22. PubMed ID: 8296647
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis.
Wong SN; Shah V; Dillon MJ
Arch Dis Child; 1998 Sep; 79(3):246-50. PubMed ID: 9875021
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of anti-neutrophil cytoplasmic antibody (ANCA) for the diagnosis of Wegener's granulomatosis in the early stage].
Maguchi S; Takizawa M; Ryu T; Oridate N; Fukuda S; Inuyama Y
Nihon Jibiinkoka Gakkai Kaiho; 1993 Aug; 96(8):1288-96. PubMed ID: 8377061
[TBL] [Abstract][Full Text] [Related]
17. Early diagnosis of otologic Wegener's granulomatosis using the serologic marker C-ANCA.
Macias JD; Wackym PA; McCabe BF
Ann Otol Rhinol Laryngol; 1993 May; 102(5):337-41. PubMed ID: 8489162
[TBL] [Abstract][Full Text] [Related]
18. Implications of c-ANCA testing for the classification of Wegener's granulomatosis: performance of different detection systems.
Specks U; Homburger HA; DeRemee RA
Adv Exp Med Biol; 1993; 336():65-70. PubMed ID: 8296676
[No Abstract] [Full Text] [Related]
19. Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study.
Girard T; Mahr A; Noël LH; Cordier JF; Lesavre P; André MH; Guillevin L
Rheumatology (Oxford); 2001 Feb; 40(2):147-51. PubMed ID: 11257150
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of testing for antineutrophil cytoplasm antibodies (ANCA) with a standard indirect immunofluorescence ANCA test in patients with upper or lower respiratory tract symptoms.
Davenport A; Lock RJ; Wallington TB
Thorax; 1994 Mar; 49(3):213-7. PubMed ID: 8202876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
